Frates James M Insider Trades

Insider Trading History

Track insider trading activity for Frates James M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $3.45M 261,628 shares
Last Trade
Mar 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.35M 95,990 shares
$14.10
$13.20
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $1.9M 143,985 shares
Last Trade
Mar 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.03M 143,985 shares
$14.10
$13.20
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $2.19M 165,638 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$115k 7,909 shares
$14.52
$13.20
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $2.29M 173,547 shares
Last Trade
Feb 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$52.1k 3,557 shares
$14.65
$13.20
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $2.34M 177,104 shares
Last Trade
Jan 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$37k 3,326 shares
$11.11
$13.20
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $3.7M 280,430 shares
Last Trade
Sep 30, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$155k 10,558 shares
$14.65
$13.20
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$353k 40,654 shares
$8.68
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$24.7k 2,845 shares
$8.68
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $187k 21,500 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$146k 21,500 shares
$6.77
$8.68
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $3.84M 290,988 shares
Last Trade
Mar 31, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$37.8k 10,896 shares
$3.47
$13.20
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $3.98M 301,884 shares
Last Trade
Mar 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$370k 102,630 shares
$3.61
$13.20
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $166k 19,154 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 19,154 shares
$6.14
$8.68
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $3.08M 233,464 shares
Last Trade
Sep 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$101k 40,000 shares
$2.53
$13.20
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $109k 12,500 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$136k 12,500 shares
$10.90
$8.68
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $2.98M 225,964 shares
Last Trade
Apr 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$241k 120,000 shares
$2.01
$13.20
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $1.78M 134,784 shares
Last Trade
Mar 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$33.6k 1,792 shares
$18.73
$13.20
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $2.01M 152,035 shares
Last Trade
Feb 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.05M 60,000 shares
$17.56
$13.20
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $1.48M 112,035 shares
Last Trade
Jan 09, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$44.4k 2,716 shares
$16.33
$13.20
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $42.7k 4,925 shares
Last Trade
Jan 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107k 4,925 shares
$21.67
$8.68
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Chief Financial Officer
Holding Value $146k 11,072 shares
Last Trade
Oct 31, 2023 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$181k 11,072 shares
$16.31
$13.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up